P05.63 The best treatment for Vestibular Schwannoma: Systematic Review of Clinical Trials and Case Series

P05.63 前庭神经鞘瘤的最佳治疗:临床试验和病例系列的系统评价

阅读:1

Abstract

BACKGROUND: Vestibular Schwannoma (VS) causes loss of hearing, loss of balance, tinnitus and even may lead to facial numbness. Various treatment choices have been increasing such as surgery, fractionated stereotactic radiotherapy (FSRT), Gamma Knife radiosurgery (GKRS), single fraction linac stereotactic radiosurgery (SFSRT) and conservative treatment. However, there is no conclusive evidence about the best treatment of VS. In this study, we aimed to systematically review and meta-analyze all possible strategies for management of VS. MATERIAL AND METHODS: We conducted a systematic electronic search in 13 electronic databases; PubMed, ScienceDirect, WHO Global Health Library, Virtual Health Library (VHL), Scopus, The Institute of Science Index (ISI), Google Scholar, Clinical trials, Controlled Trials (MRCT), Cochrane, System for Information on Grey Literature in Europe (SIGLE), EMBASE, New York Academy of Medicine Grey Literature Report (NYAM) database for relevant studies. Original studies and case series reporting treatment of VS were included. Meta-analysis with random effects models was performed for the outcomes of tumor size reduction, increase in hearing capability, and complications. RESULTS: We included 48 studies including 3531 participants. The pooled proportions and 95% confidence intervals (95%-CIs) for tumor size reduction using FSRT and GKRS were 0.34 (0.20; 0.51) and 0.53 (0.40; 0.65), respectively. The proportions and 95%-CÍs of increase in hearing capability using surgery, FSRT, and GKRS were 0.11 (0.0; 0.91); 0.08 (0.05; 0.11), and 0.08 (0.05; 0.13), respectively. The pooled proportions of complications of surgery, FSRT, GKRS, and SFSRT were 0.18 (0.10; 0.30); 0.15 (0.08; 0.24); 0.21 (0.14; 0.30); and 0.32 (0.12; 0.24), respectively. CONCLUSION: Our study highlights the efficacy and safety of different treatments for VS such as surgery, FSRT, GKRS, and SFSRT. However, there are no controlled trials to compare these different remedies. Future large scale randomized controlled trials are needed to clarify.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。